DarioHealth Corp Valuation
| DRIO Stock | USD 0.79 0.07 9.72% |
DarioHealth Corp is undervalued. DarioHealth Corp shows a prevailing Real Value of $2.53 per share. The current price of the firm is $0.79. Our model computes the value of DarioHealth Corp from reviewing the firm fundamentals such as Current Valuation of 41.84 M, shares outstanding of 34.1 M, and Profit Margin of (2.06) % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting DarioHealth Corp's valuation include:
Price Book 0.4598 | Enterprise Value 41.8 M | Enterprise Value Ebitda (0.59) | Price Sales 1.167 | Enterprise Value Revenue 1.8151 |
Undervalued
Today
Please note that DarioHealth Corp's price fluctuation is very risky at this time. Calculation of the real value of DarioHealth Corp is based on 3 months time horizon. Increasing DarioHealth Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DarioHealth Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DarioHealth Stock. However, DarioHealth Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.79 | Real 2.53 | Target 7.82 | Hype 0.79 |
The intrinsic value of DarioHealth Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DarioHealth Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DarioHealth Corp helps investors to forecast how DarioHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DarioHealth Corp more accurately as focusing exclusively on DarioHealth Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use DarioHealth Corp's intrinsic value based on its ongoing forecasts of DarioHealth Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against DarioHealth Corp's closest peers.
DarioHealth Corp Cash |
|
DarioHealth Valuation Trend
Knowing DarioHealth Corp's actual value is paramount for traders when making sound investment determinations. Using both DarioHealth Corp's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
DarioHealth Corp Total Value Analysis
DarioHealth Corp is currently forecasted to have valuation of 41.84 M with market capitalization of 26.9 M, debt of 29.54 M, and cash on hands of 67.95 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the DarioHealth Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
41.84 M | 26.9 M | 29.54 M | 67.95 M |
DarioHealth Corp Investor Information
About 18.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. DarioHealth Corp recorded a loss per share of 0.93. The entity last dividend was issued on the 18th of November 2019. The firm had 1:20 split on the 18th of November 2019. Based on the analysis of DarioHealth Corp's profitability, liquidity, and operating efficiency, DarioHealth Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.DarioHealth Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DarioHealth Corp has an asset utilization ratio of 21.11 percent. This suggests that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that DarioHealth Corp is more efficient with each dollar of assets it utilizes for everyday operations.DarioHealth Corp Ownership Allocation
DarioHealth Corp holds a total of 34.1 Million outstanding shares. DarioHealth Corp shows significant amount of outstanding shares owned by insiders and institutional investors . Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.DarioHealth Corp Profitability Analysis
The company reported the previous year's revenue of 20.35 M. Net Loss for the year was (59.43 M) with profit before overhead, payroll, taxes, and interest of 14.01 M.About DarioHealth Corp Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of DarioHealth Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of DarioHealth Corp based exclusively on its fundamental and basic technical indicators. By analyzing DarioHealth Corp's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of DarioHealth Corp's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of DarioHealth Corp. We calculate exposure to DarioHealth Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DarioHealth Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6 M | 6.3 M | |
| Pretax Profit Margin | (2.92) | (3.06) | |
| Operating Profit Margin | (2.76) | (2.90) | |
| Net Loss | (2.92) | (3.07) | |
| Gross Profit Margin | 0.29 | 0.31 |
DarioHealth Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 28.4 M |
DarioHealth Corp Current Valuation Indicators
DarioHealth Corp's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final DarioHealth Corp's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as DarioHealth Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use DarioHealth Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes DarioHealth Corp's worth.When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 0.631 | Quarterly Revenue Growth 1.11 | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.